Evangelia Damigou/LinkedIn
Nov 17, 2025, 07:32
Evangelia Damigou and Colleagues Reveal 20-Year Data on Lifestyle Shifts and Heart Risk
Hellenic Atherosclerosis Society shared a post on LinkedIn:
“How do lifestyle behaviors cluster and evolve over time?
A new study in JAPT reveals the shifting patterns of diet, activity, sleep and smoking—and their impact on 20year cardiovascular disease risk.”
Title: Shifts in Lifestyle Behavior Combinations and Cardiovascular Risk: Data from 20 Years of Follow-up (2002–2022)
Authors: Evangelia Damigou, Costas Anastasiou, Elpiniki Vlachopoulou, Konstantina Kyrili, Fotios Barkas, Evangelinos Michelis, Amalia D. Koutsogianni, Evrydiki Kravvariti, Christina Chrysohoou, Christos Pitsavos, Costas Tsioufis, Evangelos Liberopoulos, Petros P. Sfikakis, Demosthenes Panagiotakos

Read full article here.
Stay updated with Hemostasis Today.
Amalia D. Koutsogianni
cardiovascular disease risk
cardiovascular risk
Christina Chrysohoou
Christos Pitsavos
Costas Anastasiou
Costas Tsioufis
Demosthenes Panagiotakos
Elpiniki Vlachopoulou
Evangelia Damigou
Evangelinos Michelis
Evangelos Liberopoulos
Evrydiki Kravvariti
Fotios Barkas
Health
Hematology
Hemostasis
Hemostasis Today
JAPT
Konstantina Kyrili
Medicine
Petros P. Sfikakis
-
Feb 25, 2026, 16:47Alan Nurden: Platelet Defects Explain Bleeding in EHDS Patients
-
Feb 25, 2026, 16:40Mohammed Almohammadi: Uniting Leaders in Laboratory Hematology at the 1st Saudi ISLH Joint Conference
-
Feb 25, 2026, 16:37Salihu Asimawu: Inflammation Is Not a Disease – Hats Off to the Heroes Inside Us
-
Feb 25, 2026, 16:34Michael Makris: Biomarin Has Decided to Withdraw Roctavian from the Market
-
Feb 25, 2026, 16:25Tagreed Alkaltham: The Blood Banker Personality
-
Feb 25, 2026, 16:17Sanjay Ahuja: Insightful Talk on 100 Years of VWD by Jorge Di Paola
-
Feb 25, 2026, 15:20Michael Shapiro։ Creating Real Pathways for Trainees in Preventive Cardiology
-
Feb 25, 2026, 15:15Ajay Kumar: Plasma Component Quality Control Standards
-
Feb 25, 2026, 15:09Wolfgang Miesbach: Efficacy, Safety and Thrombosis Signals in Haemophilia A/B with Inhibitors